Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19914686rdf:typepubmed:Citationlld:pubmed
pubmed-article:19914686lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:19914686lifeskim:mentionsumls-concept:C0024115lld:lifeskim
pubmed-article:19914686lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:19914686lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:19914686pubmed:issue2lld:pubmed
pubmed-article:19914686pubmed:dateCreated2010-9-29lld:pubmed
pubmed-article:19914686pubmed:abstractTextTumor necrosis factor inhibitors (TNFi) are being increasingly used for a wide range of indications. There are increasing reports of pulmonary toxicity related to the use of TNFi. In this review, we have attempted to synthesize the available literature regarding noninfectious complications related to TNFi use.lld:pubmed
pubmed-article:19914686pubmed:languageenglld:pubmed
pubmed-article:19914686pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19914686pubmed:citationSubsetIMlld:pubmed
pubmed-article:19914686pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19914686pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19914686pubmed:statusMEDLINElld:pubmed
pubmed-article:19914686pubmed:monthOctlld:pubmed
pubmed-article:19914686pubmed:issn1532-866Xlld:pubmed
pubmed-article:19914686pubmed:authorpubmed-author:CalabreseLeon...lld:pubmed
pubmed-article:19914686pubmed:authorpubmed-author:KhasnisAtul...lld:pubmed
pubmed-article:19914686pubmed:copyrightInfo© 2010 Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:19914686pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19914686pubmed:volume40lld:pubmed
pubmed-article:19914686pubmed:ownerNLMlld:pubmed
pubmed-article:19914686pubmed:authorsCompleteYlld:pubmed
pubmed-article:19914686pubmed:pagination147-63lld:pubmed
pubmed-article:19914686pubmed:meshHeadingpubmed-meshheading:19914686...lld:pubmed
pubmed-article:19914686pubmed:meshHeadingpubmed-meshheading:19914686...lld:pubmed
pubmed-article:19914686pubmed:meshHeadingpubmed-meshheading:19914686...lld:pubmed
pubmed-article:19914686pubmed:meshHeadingpubmed-meshheading:19914686...lld:pubmed
pubmed-article:19914686pubmed:meshHeadingpubmed-meshheading:19914686...lld:pubmed
pubmed-article:19914686pubmed:meshHeadingpubmed-meshheading:19914686...lld:pubmed
pubmed-article:19914686pubmed:meshHeadingpubmed-meshheading:19914686...lld:pubmed
pubmed-article:19914686pubmed:year2010lld:pubmed
pubmed-article:19914686pubmed:articleTitleTumor necrosis factor inhibitors and lung disease: a paradox of efficacy and risk.lld:pubmed
pubmed-article:19914686pubmed:affiliationDepartment of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, USA.lld:pubmed
pubmed-article:19914686pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19914686pubmed:publicationTypeReviewlld:pubmed